ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Clinuvel Pharmaceuticals Ltd

Clinuvel Pharmaceuticals Ltd (UR9)

7.95
-0.02
(-0.25%)
Closed December 03 3:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.95
Bid
7.91
Ask
7.99
Volume
5,882
7.905 Day's Range 7.985
7.88 52 Week Range 10.925
Previous Close
7.97
Open
7.985
Last Trade
30
@
7.915
Last Trade Time
Average Volume (3m)
5,005
Financial Volume
-
VWAP
-

UR9 Latest News

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

MELBOURNE, Australia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- CLINUVEL has filed a New Drug Submission (NDS) to Health Canada, seeking approval for its novel photoprotective therapy SCENESSE®...

Afamelanotide in fair-skinned Parkinson’s patients

MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or...

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE®...

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists...

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March 01, 2023 (GLOBE NEWSWIRE) -- CLINUVEL (ASX: CUV) (Börse Frankfurt: UR9) (ADR Level...

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

MELBOURNE, Australia, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Executive summaryPositive Results in the Half Year to 31 December 2022 19% increase in revenues from clinical demand for SCENESSE®...

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have shown that the drug afamelanotide can reduce critical skin damage caused by ultraviolet...

CLINUVEL Trial Results Show Drug Reduces DNA Damage

MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the...

CLINUVEL progresses vitiligo treatment program

MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder vitiligo will undergo further studies in North America this year. The drug...

Positive final results in stroke

 ASX: XETRA-DAX:  Level 1 ADR:CUV UR9 CLVLY  EXECUTIVE SUMMARY afamelanotide evaluated as safe in mild to moderate arterial ischaemic stroke (NIHSS 1–15, n=6)NIHSS1 scores improved in five...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.065-0.81097941368.0158.167.90528928.01731413DE
4-0.415-4.961147638978.3658.5557.8861818.19924103DE
12-0.88-9.966024915068.839.447.8850058.49989501DE
26-1.4549999-15.47049351919.404999910.797.8850148.86481054DE
52-2.895-26.69432918410.84510.9257.8854639.04063042DE
156-3.245-28.986154533311.19511.3957.8857289.22211609DE
260-3.245-28.986154533311.19511.3957.8857289.22211609DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
213Vow ASA
0.239 €
(75.74%)
868.47k
Y920Trilogy AI Corp
0.049 €
(75.00%)
1.34k
0IU0Us Critical Metals Corp
0.059 €
(72.51%)
994.18k
VJFVital Metals Ltd
0.0019 €
(58.33%)
600.89k
NL8Genesis Ai Corp
0.0182 €
(51.67%)
2k
RUOCOcean Power Technologies
0.3445 €
(-47.16%)
3.94M
CNWCodon AG
0.0065 €
(-40.91%)
58.61k
AXIAtos SE
0.44 €
(-36.71%)
5.91M
BDDConico Ltd
0.0004 €
(-33.33%)
1.25k
SQHSpearmint Resources Inc
0.0082 €
(-31.67%)
137k
PF8European Lithium Limited
0.041 €
(30.57%)
14.71M
D7GNel ASA
0.2488 €
(-1.66%)
9.18M
AXIAtos SE
0.44 €
(-36.71%)
5.91M
RUOCOcean Power Technologies
0.3445 €
(-47.16%)
3.94M
REBArafura Rare Earths Ltd
0.0739 €
(-2.76%)
2.32M

Discussion

View Full Feed
KILLAZILLA KILLAZILLA 53 seconds ago
ANYONE TELLING OTHERS THEY NEED HELP ARE ACTUALLY THE ONE THAT NEEDS THE HELP....

PERHAPS IF you DIDN'T ACT LIKE you DO, PEOPLE WOULDN'T ACT THE WAY THEY DO IN RESPONSE TO ALL YOUR HARSH WORDS???

HOW'S THISE BAGS....
VNUE
igotthemojo igotthemojo 2 minutes ago
"It could be in the 8’s very soon again and hopefully bounce back in the near future"

i still think that $15 is possible....a drop to $9 or so and then a rise to $15...of course that could be stunted if fcel keeps selling shares...
FCEL
dstock07734 dstock07734 2 minutes ago
Thanks, ILT. Glad to know you feel fun about what I wrote.

Clearly based on the abstract from 2022, it seems like the combo trial was unmasked to the investigator at least partially and the data were available in 2022. I always think that NWBO should submit all the data related to DC
NWBO
price_and_volume price_and_volume 2 minutes ago
Still probing that low for over a month
I wish I picked up some on that dip Biggest dollar-volume since you said that has only been $1500 - I guess nobody is too interested in "picking some up" on these dips.

Maybe in the 2s?

Maybe in the 1s?

Maybe
DTII
New money98 New money98 3 minutes ago
'Now the cusip that was attached to your shares has left, just like the ticker that used to be attached to your shares has left.'


Hmmmm....https://investorshub.advfn.com/uimage/uploads/2024/12/3/ywrwqScreenshot_20241203_215450_Chrome.jpg....Fire this dude ASAP! In true Pirate
HANUMAN HANUMAN 4 minutes ago
Should have sold some ZENA when it was above 9.
EPAZ
Monroe1 Monroe1 4 minutes ago
Because there is a boat load of folks short along with some market makers as well. During lull periods the market usually trends down. The recent PR sent some shock waves and they had to bear down. The MM's are helping these shorts to exit at a profit. It's pure manipulation until such time as buyer
NBRI
easymonee easymonee 4 minutes ago
I suggest you re-read my previous post. BCAP does not need a 211 to be pink current and display unsolicited quotes. I gave you an example stock that has been trading pink current without a 211 for 3 years. It appears you did not review SPZI and the example given.

The 211 does not matt
BCAP SPZI
1vman 1vman 5 minutes ago
***** 🤪YESSIR !!!🟥 Lose lose !! 🟥🟥🟥 huge reverse split on the table for this stock to survive - CEO cannot be trusted

ENOUGH SAID HUZZAH🤪 !!!
UBQU
Humbert Humbert 5 minutes ago
Everyone should go by their own intuition - I'm here to offer my perspective. I believe the stock will reach new highs.
BNCM
rickstereo3333 rickstereo3333 6 minutes ago
"Pivot" as in conducting trials in Asia in the interim as opposed to doing a complete U-turn.

My apologies for any confusion caused.
RDGL
rogers711 rogers711 8 minutes ago
I have not read anywhere that they are pivoting... where are people getting this from? 
RDGL
StayHumble StayHumble 10 minutes ago
Yes, $UBQU💹iO does $5M🎃inRevenue Annually+Growing💹 💹w/ Facilities already in place to help make it happen. Just watch what we do!

https://x.com/CorporateUbqu/status/1767983893544566905?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E17679838935445
UBQU
tdbowieknife tdbowieknife 11 minutes ago
Hardly...

.

Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG


..
BCAP
sortagreen sortagreen 12 minutes ago
no no... You came in in the middle of that exchange... I was talking about trump.

trump won't be prosecuted because the DOJ will be headed by an appointee of his.

see
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175469494

and
Jaxxm Jaxxm 12 minutes ago
SNIPF great revenue and net profit https://www.otcmarkets.com/stock/SNIPF/news/story?e&id=3062266
SNIPF
powerbattles powerbattles 12 minutes ago
$BDPT $0.11 +83.33%
BDPTD
bleedpurple bleedpurple 13 minutes ago
Early Xmas present coming.  Waiting for an early Feb:

MDXG under $15

From ya Monk D.  Happy holidays
MDXG
hap0206 hap0206 13 minutes ago
It may come to that -- but I think the Russians will do that once Trump puts it to them -- join in the bounty of the EU or suffer the consequences
gitreal gitreal 13 minutes ago
Anyone who studies Fundamentals , knows

Curious to try to understand what you consider a "Fundamental"?

The incredible PGM assay data given in PRs but oddly missing completely from the quarterly? Would that strange omission affect the "Fundamentals"?
NBRI
StayHumble StayHumble 13 minutes ago
wow!💹per Corporate$UBQU💹"No r/s+ MERGER AQUISITION" 💹wow!
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
JD400 JD400 13 minutes ago
Miss VIXs showing her complacency

while markets are celebrating and pretending

she's signaling house cleaning

https://www.youtube.com/watch?v=k9JbEUPh7FQ
https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiw-rXL_nVngZ4PFo7FRrLAHE1Sm1ryqPXy
MUX

Your Recent History

Delayed Upgrade Clock